Skip to content
10-Q

Quarterly Report

SPRINGWORKS THERAPEUTICS, INC.

0001773427-24-000025

← back to feed
Filed
Aug 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 1, 2024 74.27M sh
Shares Diluted Q2 2024 · Jun 30, 2024 74.12M sh
Shares Diluted Q2 2024 · Jun 30, 2024 73.94M sh
Shares Diluted Q2 2024 · Jun 30, 2023 62.46M sh
Shares Diluted Q2 2024 · Jun 30, 2023 62.36M sh
Stock Repurchased Q2 2024 · Jun 30, 2024 $7.42M
Stock Repurchased Q2 2024 · Jun 30, 2023 $2.28M
Capex Q2 2024 · Jun 30, 2024 $1.55M
Capex Q2 2024 · Jun 30, 2023 $6.07M
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$120.72M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$109.63M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $79.9M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $176.05M
Stockholders Equity Q2 2024 · Jun 30, 2024 $556.73M
Stockholders Equity Q2 2024 · Mar 31, 2024 $567.44M
Stockholders Equity Q2 2024 · Dec 31, 2023 $626.22M
Stockholders Equity Q2 2024 · Jun 30, 2023 $451.44M
Stockholders Equity Q2 2024 · Mar 31, 2023 $506.92M
Stockholders Equity Q2 2024 · Dec 31, 2022 $558.19M
Current Liabilities Q2 2024 · Jun 30, 2024 $54.5M
Current Liabilities Q2 2024 · Dec 31, 2023 $78.17M
Total Liabilities Q2 2024 · Jun 30, 2024 $60.6M
Total Liabilities Q2 2024 · Dec 31, 2023 $99.57M
Current Assets Q2 2024 · Jun 30, 2024 $431.32M
Current Assets Q2 2024 · Dec 31, 2023 $500.91M
Total Assets Q2 2024 · Jun 30, 2024 $617.33M
Total Assets Q2 2024 · Dec 31, 2023 $725.79M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.54
Eps Diluted Q2 2024 · Jun 30, 2024 −$1.72
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.25
Eps Diluted Q2 2024 · Jun 30, 2023 −$2.43
Eps Basic Q2 2024 · Jun 30, 2024 −$0.54
Eps Basic Q2 2024 · Jun 30, 2024 −$1.72
Eps Basic Q2 2024 · Jun 30, 2023 −$1.25
Eps Basic Q2 2024 · Jun 30, 2023 −$2.43
Sga Expense Q2 2024 · Jun 30, 2024 $57.84M
Sga Expense Q2 2024 · Jun 30, 2024 $117.95M
Sga Expense Q2 2024 · Jun 30, 2023 $46.99M
Sga Expense Q2 2024 · Jun 30, 2023 $91.17M
Rd Expense Q2 2024 · Jun 30, 2024 $44.36M
Rd Expense Q2 2024 · Jun 30, 2024 $97.98M
Rd Expense Q2 2024 · Jun 30, 2023 $35.86M
Rd Expense Q2 2024 · Jun 30, 2023 $69.38M
Net Income Q2 2024 · Jun 30, 2024 −$39.92M
Net Income Q2 2024 · Jun 30, 2024 −$127.3M
Net Income Q2 2024 · Jun 30, 2023 −$77.93M
Net Income Q2 2024 · Jun 30, 2023 −$151.35M
Operating Income Q2 2024 · Jun 30, 2024 −$44.92M
Operating Income Q2 2024 · Jun 30, 2024 −$138.85M
Operating Income Q2 2024 · Jun 30, 2023 −$82.85M
Operating Income Q2 2024 · Jun 30, 2023 −$160.55M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $2.45M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $3.66M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $0
Cost Of Revenue Q2 2024 · Jun 30, 2023 $0
Revenue Q2 2024 · Jun 30, 2024 $59.73M
Revenue Q2 2024 · Jun 30, 2024 $80.74M
Revenue Q2 2024 · Jun 30, 2023 $0
Revenue Q2 2024 · Jun 30, 2023 $0